Stonepine Capital Management’s Molecular Templates, Inc. MTEM Stock Holding History

Stonepine Capital Management’s Portfolio MTEM Stock Details MTEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-7,647	Closed	-$463K	–	33
2018 Q4	$463K	Sell	7,647 -17,573	-70%	-$1.23M	0.41%	20
2018 Q3	$2.04M	Buy	+25,220	New	+$1.93M	1.19%	22

Other funds holding MTEM

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Stonepine Capital Management's MTEM Position: Q1 2019 in Review

Stonepine Capital Management sold out of Molecular Templates, Inc. (MTEM) in Q1 2019, closing a stake of 7,647 shares — an estimated $463K sold.

Stonepine Capital Management first reported a position in MTEM in Q3 2018 and held it in 2 quarters. The position peaked at $2.04M in Q3 2018. 64 funds tracked by Wall St. Rank hold MTEM as of Q1 2019.

Stonepine Capital Management reported no remaining Molecular Templates, Inc. position as of Q1 2019 after selling out during the quarter.
Stonepine Capital Management sold 7,647 Molecular Templates, Inc. shares in Q1 2019, an estimated $463K.
Stonepine Capital Management first reported a position in Molecular Templates, Inc. in Q3 2018 and held it in 2 quarters.
Stonepine Capital Management's Molecular Templates, Inc. position peaked at $2.04M in Q3 2018.
64 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q1 2019.

Based on Stonepine Capital Management's 13F filing for Q1 2019, filed 14 May 2019.